MA49889A - Agents antifongiques utilisés en association - Google Patents
Agents antifongiques utilisés en associationInfo
- Publication number
- MA49889A MA49889A MA049889A MA49889A MA49889A MA 49889 A MA49889 A MA 49889A MA 049889 A MA049889 A MA 049889A MA 49889 A MA49889 A MA 49889A MA 49889 A MA49889 A MA 49889A
- Authority
- MA
- Morocco
- Prior art keywords
- association
- antifungal agents
- agents used
- antifungal
- agents
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title 1
- 239000003429 antifungal agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762483647P | 2017-04-10 | 2017-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49889A true MA49889A (fr) | 2020-06-24 |
Family
ID=62063223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049889A MA49889A (fr) | 2017-04-10 | 2018-04-04 | Agents antifongiques utilisés en association |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11110102B2 (ko) |
| EP (1) | EP3609539A1 (ko) |
| JP (2) | JP7263313B2 (ko) |
| KR (1) | KR20190133251A (ko) |
| CN (1) | CN110769854B (ko) |
| AR (1) | AR113221A1 (ko) |
| AU (1) | AU2018253031B2 (ko) |
| BR (1) | BR112019021138A2 (ko) |
| CA (1) | CA3059225A1 (ko) |
| EA (1) | EA201992413A1 (ko) |
| MA (1) | MA49889A (ko) |
| MX (1) | MX2019012116A (ko) |
| TW (1) | TWI806861B (ko) |
| WO (1) | WO2018191077A1 (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020002290A2 (pt) * | 2017-08-04 | 2020-09-08 | Scynexis, Inc. | métodos de tratamento de uma infecção fúngica em um indivíduo em necessidade do mesmo, de prevenção de uma infecção fúngica em um indivíduo, e de tratamento de infecção por candidíase vulvovaginal (vvc) em um indivíduo em necessidade do mesmo |
| KR20210133241A (ko) * | 2019-02-27 | 2021-11-05 | 싸이넥시스, 인크. | 뉴모시스티스 종 폐렴의 치료 또는 예방을 위한 트리테르페노이드 항진균제 |
| CA3140637A1 (en) * | 2019-05-16 | 2020-11-19 | Scynexis, Inc. | Antifungal agents, like ibrexafungerp for candida auris decolonization |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| ES2402659T3 (es) | 2006-04-03 | 2013-05-07 | Merck Sharp & Dohme Corp. | Derivados de enfumafungina como agentes antifúngicos |
| JP5548875B2 (ja) * | 2008-08-12 | 2014-07-16 | サイネクシス，インコーポレーテッド | 抗真菌剤 |
| PT2326172E (pt) * | 2008-08-12 | 2015-02-04 | Scynexis Inc | Agentes antífúngicos |
| SI3221308T1 (sl) * | 2014-11-21 | 2018-12-31 | F2G Limited | Antimikotiki |
| ES2913111T3 (es) | 2015-01-19 | 2022-05-31 | Scynexis Inc | Novedosas sales y polimorfos de SCY-078 |
-
2018
- 2018-04-04 EA EA201992413A patent/EA201992413A1/ru unknown
- 2018-04-04 KR KR1020197032870A patent/KR20190133251A/ko active IP Right Grant
- 2018-04-04 BR BR112019021138-1A patent/BR112019021138A2/pt unknown
- 2018-04-04 MA MA049889A patent/MA49889A/fr unknown
- 2018-04-04 MX MX2019012116A patent/MX2019012116A/es unknown
- 2018-04-04 WO PCT/US2018/026088 patent/WO2018191077A1/en unknown
- 2018-04-04 AU AU2018253031A patent/AU2018253031B2/en active Active
- 2018-04-04 JP JP2020504267A patent/JP7263313B2/ja active Active
- 2018-04-04 EP EP18720489.6A patent/EP3609539A1/en active Pending
- 2018-04-04 CA CA3059225A patent/CA3059225A1/en active Pending
- 2018-04-04 CN CN201880033777.4A patent/CN110769854B/zh active Active
- 2018-04-04 US US15/945,428 patent/US11110102B2/en active Active
- 2018-04-09 AR ARP180100881A patent/AR113221A1/es unknown
- 2018-04-10 TW TW107112305A patent/TWI806861B/zh active
-
2021
- 2021-08-10 US US17/399,015 patent/US20220202833A1/en active Pending
-
2022
- 2022-12-22 JP JP2022205904A patent/JP2023030113A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018191077A1 (en) | 2018-10-18 |
| CN110769854B (zh) | 2023-01-13 |
| CA3059225A1 (en) | 2018-10-18 |
| AR113221A1 (es) | 2020-02-19 |
| TWI806861B (zh) | 2023-07-01 |
| EA201992413A1 (ru) | 2020-03-16 |
| KR20190133251A (ko) | 2019-12-02 |
| BR112019021138A2 (pt) | 2020-05-12 |
| AU2018253031B2 (en) | 2024-04-11 |
| JP2020513037A (ja) | 2020-04-30 |
| US20180325919A1 (en) | 2018-11-15 |
| TW201842915A (zh) | 2018-12-16 |
| US20220202833A1 (en) | 2022-06-30 |
| JP2023030113A (ja) | 2023-03-07 |
| US11110102B2 (en) | 2021-09-07 |
| EP3609539A1 (en) | 2020-02-19 |
| AU2018253031A1 (en) | 2019-10-31 |
| JP7263313B2 (ja) | 2023-04-24 |
| CN110769854A (zh) | 2020-02-07 |
| MX2019012116A (es) | 2019-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3612531T3 (da) | Apoptose-inducerende midler | |
| DK3687994T3 (da) | Gadolinium-bærende pcta-baserede kontrastmidler | |
| DK3697376T3 (da) | Sammensætning | |
| DOS2017000228S (es) | Envase | |
| DK3528902T3 (da) | Ringegelsammensætning | |
| DOS2017000229S (es) | Envase | |
| DE112018004750A5 (de) | Hand-werkzeugmaschine | |
| DK3395738T3 (da) | Dispenser | |
| MA49889A (fr) | Agents antifongiques utilisés en association | |
| FR3049449B3 (fr) | Brasero portatif | |
| ITUA20162425A1 (it) | Composizione oftalmica che comprende PVP-I | |
| DK3416502T3 (da) | Glykæmisk-reducerende sammensætning | |
| ES1209313Y (es) | Composicion liofilizada | |
| IT201700095717A1 (it) | Composizione erbicida | |
| FI11737U1 (fi) | Säiliö | |
| ES1166710Y (es) | Dispensador portátil | |
| IT201600111393A1 (it) | Composizione antifungina | |
| IT201700078091A1 (it) | Nuove composizioni antifungine | |
| DK3434403T3 (da) | Arbejdsstation | |
| DK3476320T3 (da) | Intramedullær fikseringsanordning | |
| DOS2017000170S (es) | Contenedor | |
| ES1155733Y (es) | Mochila antirrobo | |
| DK3410854T3 (da) | Mikrobicid sammensætning | |
| IT201700121095U1 (it) | Rinforza spalle | |
| UY4632S (es) | Envase |